Martin Leslie

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

R.D. James, Rob Glynne‐Jones, Helen Meadows et al. · The Lancet Oncology · 2013 · 733 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Arnaud Roth, Nicola Fazio, Roger Stupp et al. · Journal of Clinical Oncology · 2007 · 244 citations · Full text

Medicine, Oncology, Pharmacology +14

EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer

Rob Glynne‐Jones, Helen Meadows, Susan Wan et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 145 citations

Medicine, Oncology, Pharmacology +16

A Brief Report on the Safety Study of Induction Chemotherapy Followed by Synchronous Radiotherapy and Cetuximab in Stage III Non-small Cell Lung Cancer (NSCLC): SCRATCH Study

Simon Hughes, Aisha Miah, Shahreen Ahmad et al. · Journal of Thoracic Oncology · 2008 · 64 citations · Full text

Medicine, Oncology, Chemotherapy +12

A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan

Caio Rocha‐Lima, Eriberto de Queiroz Marques, Soley Bayraktar et al. · Cancer Chemotherapy and Pharmacology · 2014 · 16 citations

Medicine, Oncology, Pharmacology +12